High mobility group nucleosomal binding domain 2 pseudogene 20 (HMGN2P20)

HMGN2P20, also known as high mobility group nucleosomal binding domain 2 pseudogene 20 (HMGN2P20), is a human pseudogene located in the genome that resembles its protein-coding parent gene HMGN2 but contains mutations rendering it unable to encode a functional protein[3][5][6]. Like other pseudogenes, it may participate in noncoding RNA regulatory mechanisms, such as acting as a competitive endogenous RNA (ceRNA) or interfering with microRNA pathways, but there is no specific evidence of functional significance, disease association, or druggability for HMGN2P20 itself[1][6]. Pseudogenes as a class have sometimes been implicated in gene expression regulation and, rarely, used as biomarkers in oncology, but HMGN2P20 has not been reported to have such properties[4][6]. The molecule's existence should not be confused with its protein-coding parent, "High mobility group nucleosomal binding domain 2" (HMGN2), which is a nuclear protein involved in chromatin structure and gene regulation.

None. No drugs target HMGN2P20, and its RNA (if transcribed) is not known to participate in recognized drug mechanisms